Bio-Rad Laboratories, Inc. Class A Common Stock vs Expedia Group Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Expedia Group Inc trades at $328 (market cap $38.53B). The key difference: Expedia Group Inc is far larger — about 4.1× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Expedia Group Inc pays a 0.6% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | EXPE | |
|---|---|---|
Market Cap | $9.43B | $38.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $356.25 | $321.07 |
52-Week Low | $241.71 | $188.51 |
Enterprise Value | $9.18B | $37.09B |
Dividend Yield | — | 0.6% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →